Melanoma/Skin Cancer News

The FDA announced several regulatory actions the past few weeks.

The strongest predictor of lentigo maligna melanoma progression is histologic margin status, and patients with margins less than 3 mm should consider re-excision, according to a study.

Early detection continues to fail as an intervention for melanoma among patients with skin of color, prompting the need for other approaches, according to a study.

The University of Texas MD Anderson Cancer Center has retained its distinction as the No. 1 cancer hospital in the country.

Organ transplant recipients diagnosed with cutaneous squamous cell carcinoma are more likely to experience recurrence, metastasis and death from this cancer compared with non-organ transplant recipients, according to a study.

The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended the approval of Opdivo for melanoma treatment in patients aged 12 years and older, according to a Bristol Myers Squibb press release.

Patient satisfaction after Mohs micrographic surgery is affected by numerous factors that may change over time, according to a study.

Patients tested with the DecisionDx-Melanoma 31-gene expression profile test experienced 29% lower melanoma-specific mortality and 17% lower overall mortality compared with untested patients, according to a study.

When used in tandem with clinical and dermoscopic examination, optical coherence tomography significantly improved the ability to detect recurrent or residual basal cell carcinomas after topical treatment, according to a study.

Falls in an inpatient cancer rehabilitation unit occurred less frequently than previous studies have estimated and usually caused patients no harm, according to data published in JCO Oncology Practice.